Merck & Co., Inc. - Jun 2, 2021 Form 4 Insider Report for Organon & Co. (OGN)

Role: 10%+ Owner
Signature: Merck & Co., Inc. /s/ Kelly E.W. Grez, Deputy Corporate Secretary
Stock symbol: OGN
Transactions as of: Jun 2, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/4/2021, 04:46 PM
Previous filing: May 7, 2021
Next filing: Jan 17, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Other		-254M	-100%		0	Jun 2, 2021	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Merck & Co., Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Pursuant to the Separation and Distribution Agreement, dated as of June 2, 2021, Merck & Co., Inc. ("Merck") distributed to the holders of its common stock by means of a pro-rata distribution without consideration an aggregate of 253,516,000 shares of common stock of Organon & Co. (the "Separation").
F2	In connection with the Separation, the 100 shares of common stock of Organon & Co. held by Merck were reclassified into 253,516,000 shares of common stock of Organon & Co.